Select therapeutic use:

Edema:

Indications for DYAZIDE:

Edema.

Adult Dosage:

1–2 caps once daily.

Children Dosage:

Not established.

DYAZIDE Contraindications:

Hyperkalemia. Renal impairment. Anuria. Sulfonamide allergy. Concomitant potassium or K+-sparing diuretics.

Boxed Warning:

Hyperkalemia.

DYAZIDE Warnings/Precautions:

Risk of hyperkalemia; monitor frequently. Discontinue if serum potassium >5.5mEq/L or <3mEq/L. Diabetes. Acidosis predisposition. Electrolyte imbalance. Hypochloremia with metabolic alkalosis. Excess diuresis. History of renal stones. Gout. Surgery. SLE. Monitor electrolytes, renal function. Hepatic impairment: monitor for hepatic coma, if confusion increases, discontinue for a few days. Severely ill. Elderly. Pregnancy. Nursing mothers: not recommended.

DYAZIDE Classification:

Diuretic (K+ sparing) + (thiazide).

DYAZIDE Interactions:

Digoxin, lithium toxicity. Hyperkalemia more likely with ACE inhibitors, parenteral penicillin G. Hypokalemia with ACTH, corticosteroids, amphotericin B. Hyponatremia with sulfonylureas. NSAIDs may cause renal failure. Adjust antidiabetic, antigout medications. May potentiate nondepolarizing muscle relaxants, antihypertensives. Antagonizes oral anticoagulants, methenamine. May interfere with parathyroid tests.

Adverse Reactions:

Drowsiness, muscle cramps, weakness, headache, GI disturbances, dizziness, impotence, arrhythmias, hypotension, dry mouth, urine discoloration; HCTZ: increased risk for non-melanoma skin cancer.

Generic Drug Availability:

YES

How Supplied:

Caps—100

Pricing for DYAZIDE

37.5mg/25mg capsule (Qty: 90)
Appx. price $15
GoodRx

Hypertension:

Indications for DYAZIDE:

Hypertension when normokalemia is essential.

Adult Dosage:

1–2 caps once daily.

Children Dosage:

Not established.

DYAZIDE Contraindications:

Hyperkalemia. Renal impairment. Anuria. Sulfonamide allergy. Concomitant potassium or K+-sparing diuretics.

Boxed Warning:

Hyperkalemia.

DYAZIDE Warnings/Precautions:

Risk of hyperkalemia; monitor frequently. Discontinue if serum potassium >5.5mEq/L or <3mEq/L. Diabetes. Acidosis predisposition. Electrolyte imbalance. Hypochloremia with metabolic alkalosis. Excess diuresis. History of renal stones. Gout. Surgery. SLE. Monitor electrolytes, renal function. Hepatic impairment: monitor for hepatic coma, if confusion increases, discontinue for a few days. Severely ill. Elderly. Pregnancy. Nursing mothers: not recommended.

DYAZIDE Classification:

Diuretic (K+ sparing) + (thiazide).

DYAZIDE Interactions:

Digoxin, lithium toxicity. Hyperkalemia more likely with ACE inhibitors, parenteral penicillin G. Hypokalemia with ACTH, corticosteroids, amphotericin B. Hyponatremia with sulfonylureas. NSAIDs may cause renal failure. Adjust antidiabetic, antigout medications. May potentiate nondepolarizing muscle relaxants, antihypertensives. Antagonizes oral anticoagulants, methenamine. May interfere with parathyroid tests.

Adverse Reactions:

Drowsiness, muscle cramps, weakness, headache, GI disturbances, dizziness, impotence, arrhythmias, hypotension, dry mouth, urine discoloration; HCTZ: increased risk for non-melanoma skin cancer.

Generic Drug Availability:

YES

How Supplied:

Caps—100

Pricing for DYAZIDE

37.5mg/25mg capsule (Qty: 90)
Appx. price $15
GoodRx